PMC:7445716 / 20595-20908 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T75","span":{"begin":40,"end":49},"obj":"Body_part"},{"id":"T76","span":{"begin":137,"end":140},"obj":"Body_part"},{"id":"T77","span":{"begin":287,"end":290},"obj":"Body_part"}],"attributes":[{"id":"A75","pred":"fma_id","subj":"T75","obj":"http://purl.org/sig/ont/fma/fma9712"},{"id":"A76","pred":"fma_id","subj":"T76","obj":"http://purl.org/sig/ont/fma/fma24890"},{"id":"A77","pred":"fma_id","subj":"T77","obj":"http://purl.org/sig/ont/fma/fma20935"}],"text":"Chan et al. [13] USA 84 M 16 days after Hands and feet paraesthesia, progressive gait disturbance Bilateral facial weakness, progressive arm weakness, neuromuscular respiratory failure Yes (not specified autonomic dysfunction) Yes 25 days after the onset of symptoms Fever NA Clinical + CSF 2 Classic sensorimotor"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T46","span":{"begin":40,"end":45},"obj":"Body_part"},{"id":"T47","span":{"begin":50,"end":54},"obj":"Body_part"},{"id":"T48","span":{"begin":137,"end":140},"obj":"Body_part"}],"attributes":[{"id":"A46","pred":"uberon_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/UBERON_0002398"},{"id":"A47","pred":"uberon_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/UBERON_0002387"},{"id":"A48","pred":"uberon_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/UBERON_0001460"}],"text":"Chan et al. [13] USA 84 M 16 days after Hands and feet paraesthesia, progressive gait disturbance Bilateral facial weakness, progressive arm weakness, neuromuscular respiratory failure Yes (not specified autonomic dysfunction) Yes 25 days after the onset of symptoms Fever NA Clinical + CSF 2 Classic sensorimotor"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T233","span":{"begin":165,"end":184},"obj":"Disease"}],"attributes":[{"id":"A233","pred":"mondo_id","subj":"T233","obj":"http://purl.obolibrary.org/obo/MONDO_0021113"}],"text":"Chan et al. [13] USA 84 M 16 days after Hands and feet paraesthesia, progressive gait disturbance Bilateral facial weakness, progressive arm weakness, neuromuscular respiratory failure Yes (not specified autonomic dysfunction) Yes 25 days after the onset of symptoms Fever NA Clinical + CSF 2 Classic sensorimotor"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T134","span":{"begin":137,"end":140},"obj":"http://www.ebi.ac.uk/efo/EFO_0001410"}],"text":"Chan et al. [13] USA 84 M 16 days after Hands and feet paraesthesia, progressive gait disturbance Bilateral facial weakness, progressive arm weakness, neuromuscular respiratory failure Yes (not specified autonomic dysfunction) Yes 25 days after the onset of symptoms Fever NA Clinical + CSF 2 Classic sensorimotor"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T48","span":{"begin":273,"end":275},"obj":"Chemical"}],"attributes":[{"id":"A48","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"}],"text":"Chan et al. [13] USA 84 M 16 days after Hands and feet paraesthesia, progressive gait disturbance Bilateral facial weakness, progressive arm weakness, neuromuscular respiratory failure Yes (not specified autonomic dysfunction) Yes 25 days after the onset of symptoms Fever NA Clinical + CSF 2 Classic sensorimotor"}

{"project":"LitCovid-sentences","denotations":[{"id":"T134","span":{"begin":0,"end":313},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Chan et al. [13] USA 84 M 16 days after Hands and feet paraesthesia, progressive gait disturbance Bilateral facial weakness, progressive arm weakness, neuromuscular respiratory failure Yes (not specified autonomic dysfunction) Yes 25 days after the onset of symptoms Fever NA Clinical + CSF 2 Classic sensorimotor"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T154","span":{"begin":81,"end":97},"obj":"Phenotype"},{"id":"T155","span":{"begin":98,"end":123},"obj":"Phenotype"},{"id":"T156","span":{"begin":165,"end":184},"obj":"Phenotype"},{"id":"T157","span":{"begin":204,"end":225},"obj":"Phenotype"},{"id":"T158","span":{"begin":267,"end":272},"obj":"Phenotype"}],"attributes":[{"id":"A154","pred":"hp_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/HP_0001288"},{"id":"A155","pred":"hp_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/HP_0001349"},{"id":"A156","pred":"hp_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/HP_0002878"},{"id":"A157","pred":"hp_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/HP_0012332"},{"id":"A158","pred":"hp_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/HP_0001945"}],"text":"Chan et al. [13] USA 84 M 16 days after Hands and feet paraesthesia, progressive gait disturbance Bilateral facial weakness, progressive arm weakness, neuromuscular respiratory failure Yes (not specified autonomic dysfunction) Yes 25 days after the onset of symptoms Fever NA Clinical + CSF 2 Classic sensorimotor"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T187","span":{"begin":50,"end":54},"obj":"UBERON:0002387"},{"id":"T188","span":{"begin":108,"end":114},"obj":"UBERON:0001456"},{"id":"T189","span":{"begin":137,"end":140},"obj":"UBERON:0001460"},{"id":"T190","span":{"begin":165,"end":176},"obj":"UBERON:0001004"},{"id":"T191","span":{"begin":227,"end":233},"obj":"PR:Q04736"}],"text":"Chan et al. [13] USA 84 M 16 days after Hands and feet paraesthesia, progressive gait disturbance Bilateral facial weakness, progressive arm weakness, neuromuscular respiratory failure Yes (not specified autonomic dysfunction) Yes 25 days after the onset of symptoms Fever NA Clinical + CSF 2 Classic sensorimotor"}